Skip to Main Content
Contribute Try STAT+ Today

As Americans grapple with the rising cost of medicines, a new analysis shows that the U.S. had the highest spending per capita among nearly a dozen other high-income countries.

Specifically, U.S. spending per capita on pharmaceuticals was $1,443, despite the fact that generics represented 84 percent of the U.S. market, the largest tally among the 11 countries that were examined. The mean spending per capita was $749, according to the analysis, which was published in the Journal of the American Medical Association. Retail spending per capita was also highest in the U.S., at $1,026.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • After MD Medicaid stopped paying on July 31, 2013 for the three Brand Name Anti-Seizure Drugs which I have to take daily to treat my Epilepsy I spent $16, 300 on these Anti-Seizure Drugs . This is a tremendous amount of money which I did not have to be spending. Linda Ennis

Comments are closed.